The Trump administration is preparing to slap tariffs on imported pharmaceuticals within the next month or two, Commerce Secretary Howard Lutnick said Sunday (April 13), citing national security concerns. The Association for Accessible Medicines (AAM), which represents generic and biosimilar drug manufacturers, pushed back Monday (April 14) on the plan, warning it could deepen existing drug shortages, raise prices and harm patient access. The Department of Commerce has launched a Section 232 investigation under the Trade Expansion Act of 1962...